摘要
肾细胞癌(renalcellcarcinoma,RCC)占成人恶性肿瘤的2%~3%,全球每年有超过20万例新发病例及超过10万例死亡病例。约1/3患者就诊前已出现转移,超过40%的局限性RCC患者术后复发。
出处
《中华临床医师杂志(电子版)》
CAS
2011年第3期1-3,共3页
Chinese Journal of Clinicians(Electronic Edition)
参考文献20
-
1Lam JS,Klatte T,Breda A.Staging of renal cell carcinoma:Current concepts.Indian J Urol,2009,25(4):446-454.
-
2Lam JS,Breda A,Belldegrun AS,et al.Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.J Clin Oncol,2006,24(35):5565-5575.
-
3Leibovich BC,Blute ML,Cheville JC,et al.Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.J Urol,2004,171(3):1066-1070.
-
4Klatte T,Patard JJ,Goel RH,et al.Prognostic impact of tumor size on pT2 renal cell carcinoma:an international multicenter experience.Nat Clin Pract Urol,2007,4(12):648-649.
-
5Frank I,Blute ML,Leibovich BC,et al.pT2 classification for renal cell carcinoma.Can its accuracy be improved? J Urol,2005,173(2):380-384.
-
6Ku JH,Moon KC,Kwak C,et al.External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.Urology,2009,74(2):359-363.
-
7Thompson RH,Leibovich BC,Cheville JC,et al.Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol,2005,173(3):918-921.
-
8Jung ST,Ro JY,Truong LD,et al.Reappraisal of T3N0 /NxM0 renal cell carcinoma:significance of extent of fat invasion,renal vein invasion and adrenal invasion.Hum Pathol,2008,39(11):1689-1694.
-
9Ficarra V,Novara G,Iafrate M,et al.Proposal for Reclassification of the TNM Staging System in Patients with Locally Advanced (pT3-4) Renal Cell Carcinoma According to the Cancer-Related Outcome.Eur Urol,2007,51(3):722-731;discussion 729-731.
-
10Siemer S,Lehmann J,Kamradt J,et al.Adrenal metastases in 1635 patients with renal cell carcinoma:outcome and indication for adrenalectomy.J Urol,2004,171(6 Pt 1):2155-2159.
同被引文献52
-
1张开山,王正滨,田飞,刘荣桂,张海燕,闫志梅.彩色多普勒超声诊断肾细胞癌及术前分期评价[J].中华医学超声杂志(电子版),2013,10(1):74-78. 被引量:5
-
2王霄英,范诒忠,梁妍,谢晟,孙晓伟,蒋学祥.磁共振成像对肾癌分期的价值[J].中国医学影像技术,2004,20(11):1717-1720. 被引量:5
-
3彭令荣,韩希年.肾癌组织病理亚型的CT诊断[J].国外医学(临床放射学分册),2006,29(3):195-198. 被引量:19
-
4韩希年,彭令荣,刘光华,王俭.300例肾细胞癌CT表现分析[J].中华放射学杂志,2007,41(5):510-513. 被引量:34
-
5郝楠馨,常时新,曹开明,刘光华.螺旋CT扫描在肾癌术前分期中的应用价值[J].中华泌尿外科杂志,2007,28(6):372-375. 被引量:3
-
6l,am JS, Breda A, Belldegrun AS, et al. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. J Clin Oneol, 2006,24(35) :5565-5575.
-
7Sheth S, Seatarige JC, Horton KM, et al. Current concepts in the diagnosis and management of renal cell carcinoma: Role of multidetector ct and three-dimensional CT. Radiographics, 2001, 21 Spec No:S237-S254.
-
8Russo P. Renal cell carcinoma: Presentation, taging, and surgical treatment. Seminars Oncol, 2000,27(2):160-176.
-
9Novara G, Ficarra V, Antonelli A, et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients trea- ted for renal cell carcinoma: Are further improvements needed? Eur Urol, 2010,58(4) :588-595.
-
10Eggener S. TNM staging for renal cell carcinoma: time for a new method. Eur Urol, 2010,58(4) :517-519.
引证文献3
-
1何花,郭玉林,朱凯,来彦博,刘珊,张社宁.肾细胞癌CT Robson分期与TNM分期对比分析[J].中国医学影像技术,2013,29(12):2007-2010. 被引量:8
-
2杨朝慧,李健丁.肾癌常见亚型病理特点及CT表现[J].中国中西医结合影像学杂志,2014,12(3):286-288. 被引量:3
-
3张毅,袁梅,刘薇,王伟,王正滨,孙立江,李玉军.彩色多普勒超声诊断肾细胞癌及其 TNM分期的临床研究[J].中国基层医药,2015,22(12):1862-1865. 被引量:4
二级引证文献15
-
1罗实,张莹莹,徐荣天.平扫CT鉴别肾透明细胞癌与高密度肾囊肿的应用价值[J].实用放射学杂志,2014,30(11):1855-1857. 被引量:2
-
2冯凯,谢宝君.64层CT三维重建对肾癌分期及后腹腔镜肾癌手术的应用价值[J].现代仪器与医疗,2015,21(2):11-15. 被引量:6
-
3黄霖,唐汐,郭诗武.儿童肾母细胞瘤的CT表现分析[J].中国中西医结合影像学杂志,2015,13(3):321-322. 被引量:4
-
4吕春英.超声在诊断肾肿瘤上的价值分析[J].中国城乡企业卫生,2016,31(6):114-115. 被引量:1
-
5韩焱,关文华,史展,周金金,臧志娜.MSCT3期增强扫描诊断肾透明细胞癌术前T分期的准确性与限度[J].中国中西医结合影像学杂志,2016,14(4):392-395. 被引量:5
-
6李晓娜,张红霞.IL-17和VEGF表达水平与不同分期肾癌与肿瘤血管生成的关系研究[J].中国实用医刊,2017,44(9):14-16. 被引量:2
-
7吴进锋,白国栋,王菲,王敏茹,张华文.128排螺旋CT血管造影术在肾细胞癌术前分期中的应用[J].中国肿瘤临床与康复,2017,24(12):1445-1447. 被引量:2
-
8张砚满,吴献华.肾细胞癌侵犯肾包膜的多层螺旋CT征象[J].江苏医药,2017,43(19):1417-1419. 被引量:1
-
9任金武,马聪敏,张立红,马立新,王谦,王新刚.肾透明细胞癌的CT征象与预后关系分析[J].中国临床医学影像杂志,2018,29(1):28-33. 被引量:15
-
10宣洪伟.彩色多普勒超声诊断肾细胞癌及术前分期的临床应用[J].中国医疗器械信息,2018,24(20):134-135.
-
1孙守田,汪岩,许宁,金美善,崔延义,张小军.Vimentin在肾癌组织中的表达及临床意义[J].中国实验诊断学,2011,15(2):251-253. 被引量:3
-
2邹高德,葛根,孙锡林.肾细胞癌bcl-2及ki-67的免疫组化研究[J].江西医学院学报,2002,42(1):33-35. 被引量:1
-
3王霄英,范诒忠,梁妍,谢晟,孙晓伟,蒋学祥.磁共振成像对肾癌分期的价值[J].中国医学影像技术,2004,20(11):1717-1720. 被引量:5
-
4王赞礼,万福庆.多层螺旋CT在肾癌分期中的应用价值分析[J].中外医疗,2011,30(16):173-173.
-
5王伟,王晓雄.CT对肾癌诊断和分期的价值[J].中华泌尿外科杂志,1998,19(4):205-207. 被引量:3
-
6徐万海,王晓民,李际桐,高琳,王科亮,苏宇,刘岩,李庆,李建章.突变型p53和CD44v6基因产物在肾肿瘤表达研究[J].哈尔滨医科大学学报,2006,40(5):385-387.
-
7金家岩,宋慧琴,张君娜,王连渠.偶发肾透明细胞癌临床病理分析[J].中国误诊学杂志,2010,10(31):7648-7648. 被引量:1
-
8方立,刘修恒,罗洪波.肾细胞癌中COX-2与血管生成的相关性研究[J].武汉大学学报(医学版),2006,27(2):152-155. 被引量:6
-
9谢庆祥,林吓聪,张闽峰,郭以河,赵力.肾癌组织中IGF-Ⅰ和IGF-ⅠR表达及其临床意义[J].现代泌尿外科杂志,2005,10(6):317-319. 被引量:1
-
10王家菁,盛新福.BCL-2、PCNA在肾癌中的表达及临床意义[J].现代泌尿外科杂志,1999,4(2):77-80.